The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
In vitro bioactivity of silicon‐substituted hydroxyapatites
Abstract
Silicon‐containing hydroxyapatites were synthesized by the controlled crystallization method. Chemical analysis, N 2 adsorption, Hg porosimetry, X‐ray diffraction, scanning electron microscopy‐energy‐dispersive X‐ray spectroscopy, and X‐ray photoelectron spectroscopy (XPS) were used to characterize the hydroxyapatite and to monitor the development of a calcium phosphate layer onto the surface of the substrate immersed in a simulated body fluid, that is, in vitro bioactivity tests. The influence of the silicon content and the nature of the starting calcium and phosphorus sources on the in vitro bioactivity of the resulting materials were studied. A sample of silicocarnotite, whose structure is related to that of hydroxyapatite and contains isolated SiO 44− anions that isomorphically substitute some PO 43− anions, was prepared and used as reference material for XPS studies. An increase of the unit cell parameters with the Si content was observed, which indicated that SiO 44− units are present in lattice positions, replacing some PO 43− groups. By using XPS it was possible to assess the presence of monomeric SiO 44− units in the surface of apatite samples containing 0.8 wt % of silicon, regardless the nature of the starting raw materials, either Ca(NO 3)2/(NH 4)2 HPO 4/Si(OCOCH 3)4 or Ca(OH)2/H 3 PO 4/Si(OCOCH 3)4. However, an increase of the silicon content up to 1.6 wt % leads to the polymerization of the silicate species at the surface. This technique shows silicon enrichment at the surface of the three samples. The in vitro bioactivity assays showed that the formation of an apatite‐like layer onto the surface of silicon‐containing substrates is strongly enhanced as compared with pure silicon‐free hydroxyapatite. The samples containing monomeric silicate species showed higher in vitro bioactivity than that of silicon‐rich sample containing polymeric silicate species. The use of calcium and phosphate salts as precursors lead to materials with higher bioactivity. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 66A: 364–375, 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1999) · Choice Reviews Online · doi:10.5860/choice.37-0940 · Cited by 14,314
Cited by
Hoppe, A., Güldal, N. S., & Boccaccini, A. R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.004 · Cited by 2,608
Calcium phosphates in biomedical applications: materials for the future?
Habraken, W., Habibovic, P., Epple, M., & Bohner, M. (2016) · Materials Today · doi:10.1016/j.mattod.2015.10.008 · Cited by 857
Hing, K. A., Revell, P. A., Smith, N., & Buckland, T. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.039 · Cited by 375
Kaur, G., Kumar, V., Baino, F., Mauro, J. C., Pickrell, G., Evans, I., & Bretcanu, O. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.109895 · Cited by 330
Silicon-substituted calcium phosphates – A critical view
Bohner, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.007 · Cited by 278
Metadata
- Authors
- Balas, F., Pérez‐Pariente, J., & Vallet‐Regí, M.
- Venue
- Journal of Biomedical Materials Research Part A
- Publisher
- Wiley
- Published
- 2003-07-09
- Volume
- 66A
- Issue
- 2
- Pages
- 364-375
- ISSN
- 1549-3296 (ISSN-L)
- 1552-4965
- OpenAlex
- W2070169744
- Cited by
- 192
- References
- 1
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vitro bioactivity of silicon‐substituted hydroxyapatites. https://app.cochat.ai/papers/10.1002/jbm.a.10579
- The paper
- Balas, F., Pérez‐Pariente, J., & Vallet‐Regí, M. (2003). In vitro bioactivity of silicon‐substituted hydroxyapatites. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.10579
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.